Long-term steroids might not increase lymphoma risk for some patients
Caroline Barranco
This article has no abstract so we have provided the first paragraph of the full text.
Some studies have suggested that long-term steroid use doubles a patient's risk of lymphoma; however, many of the inflammatory conditions currently treated with steroids or other potentially lymphoma-inducing drugs themselves carry an increased lymphoma risk. A new, large, population-based case–control study, using prospectively recorded data from the Swedish Cancer Register, aimed to avoid these confounding factors by examining lymphoma risk in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), conditions that are uniformly and successfully treated with 1–2 years of steroids as single immunosuppressive therapy.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.